Home>
US Stocks>
Citius Pharmaceuticals

Citius Pharmaceuticals share price today

(CTXR)

Citius Pharmaceuticals share price is $2.6 & ₹220.94 as on 21 Dec 2024, 2.30 'hrs' IST

$2.6

▲

0.03

(1.17%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Citius Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Citius Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Citius Pharmaceuticals. Get details on the Indian mutual funds that are investing in Citius Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Citius Pharmaceuticals's financials.

Citius Pharmaceuticals share price movements

Today's Low: $2.48
Today's High: $2.74
$2.60
4.62%
Downside
Day's Volatility :9.49%
Upside
5.11%
52 Weeks Low: $2.44
52 Weeks High: $26.75
$2.60
6.15%
Downside
52 Weeks Volatility :90.88%
Upside
90.28%

Citius Pharmaceuticals Returns

Period	Citius Pharmaceuticals Inc	Index (Russel 2000)
3 Months	-81.12%	0.0%
6 Months	-83.69%	0.0%
1 Year	-86.95%	0.0%
3 Years	-93.7%	-19.7%

Citius Pharmaceuticals Key Statistics

in dollars & INR

Previous Close	$2.57
Open	$2.51
Today's High	$2.74
Today's Low	$2.48
Market Capitalization	$87.1M
Today's Volume	$100.0K
52 Week High	$26.75
52 Week Low	$2.44
Revenue TTM	$0.0
EBITDA	$-41.1M
Earnings Per Share (EPS)	$-0.24
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-41.49%

How to invest in Citius Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Citius Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Citius Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Citius Pharmaceuticals or CTXR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Citius Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Citius Pharmaceuticals shares which would translate to 0.327 fractional shares of Citius Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Citius Pharmaceuticals, in just a few clicks!

Returns in Citius Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

Citius Pharmaceuticals investment value today

Current value as on today

₹1,89,144

Returns

₹89,144

(+89.14%)

Returns from Citius Pharmaceuticals Stock

₹86,948 (false-86.95%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Citius Pharmaceuticals

72%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Citius Pharmaceuticals on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 72% more investors are searching Citius Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Citius Pharmaceuticals

Armistice Capital, LLC
3.77%
Vanguard Group Inc
3.33%
Geode Capital Management, LLC
0.97%
BlackRock Inc
0.93%
Millennium Management LLC
0.60%
Advisor Group Holdings, Inc.
0.48%

Analyst Recommendation on Citius Pharmaceuticals

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Citius Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Citius Pharmaceuticals

What analysts predicted

Upside of 79.62%

Current:

$2.60

Target:

$4.67

Insights on Citius Pharmaceuticals

Price Movement
In the last 1 month, CTXR stock has moved down by -37.0%
CTXR vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 121.7%
CTXR vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 116.6%

Citius Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Citius Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Citius Pharmaceuticals Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Citius Pharmaceuticals Inc	-37.01%	-83.69%	-86.95%	-93.7%	-86.32%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.11%	13.66%	87.56%
Biontech Se	4.48%	30.56%	7.36%	-56.46%	225.6%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.49%	30.99%	109.19%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-1.97%	78.33%	80.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Citius Pharmaceuticals Inc	NA	NA	0.0	-0.2	-0.41	-0.25	NA	0.47
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Citius Pharmaceuticals Inc	Buy	$87.1M	-86.32%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	87.56%	17.51	33.61%
Biontech Se	Buy	$26.7B	225.6%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	109.19%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.59%	32.84	-4.51%

About Citius Pharmaceuticals

citius pharmaceuticals, inc., a specialty pharmaceutical company, develops and commercializes critical care products. it primarily focuses on developing anti-infective, cancer care, prescription, and mesenchymal stem cell therapy products. the company is developing mino-lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter, which is in phase iii clinical trials; mino-wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; halo-lido, a corticosteroid-lidocaine topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and novecite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome. citius pharmaceuticals, inc. was founded in 2007 and is headquartered in cranford, new jersey.

Organization	Citius Pharmaceuticals
Employees	22
CEO	Mr. Leonard L. Mazur
Industry	Health Technology

Management People of Citius Pharmaceuticals

Name	Title
Mr. Leonard L. Mazur	Co-Founder, CEO, Chairman & Secretary
Mr. Myron Z. Holubiak	Co-Founder & Executive Vice Chairman
Dr. Myron S. Czuczman M.D.	Executive VP & Chief Medical Officer
Mr. Jaime Bartushak	Chief Business Officer, CFO & Chief Accounting Officer
Mr. Gary F. Talarico	Executive Vice President of Operations
Ms. Ilanit Allen	Vice President of Investor Relations & Corporate Communications
Dr. Alan Lader Ph.D.	Senior VP and Head of Clinical Operations & Quality Assurance
Mr. Dhananjay G. Wadekar	Senior Vice President of Business Strategy
Mr. Kelly Creighton Ph.D.	Executive Vice President of Chemistry, Manufacturing & Controls
Mr. Nikolas Burlew	Executive Vice President of Quality Assurance

Important FAQs about investing in Citius Pharmaceuticals from India :

What is Citius Pharmaceuticals share price today?

Citius Pharmaceuticals share price today stands at $2.60, Open: $2.51 ; Previous Close: $2.57 ; High: $2.74 ; Low: $2.48 ; 52 Week High: $26.75 ; 52 Week Low: $2.44. The stock opens at $2.51, after a previous close of $2.57. The stock reached a daily high of $2.74 and a low of $2.48, with a 52-week high of $26.75 and a 52-week low of $2.44.

Can Indians buy Citius Pharmaceuticals shares?

Yes, Indians can invest in the Citius Pharmaceuticals (CTXR) from India.

With INDmoney, you can buy Citius Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Citius Pharmaceuticals at zero transaction cost.

How can I buy Citius Pharmaceuticals shares from India?

It is very easy to buy Citius Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Citius Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Citius Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Citius Pharmaceuticals stocks?

To start investing in Citius Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.